Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Franciso Bautista
Observed name:
Francisco Bautista
Institutions:
Hospital Infantil Universitario Niño Jesús,
Princess Máxima Center
Observed institutions:
Hospital Infantil Universitario Niño Jesús,
Princess Máxima Center
ORCID:
0000-0002-0421-8862
Observed ORCID:
0000-0002-0421-8862
OpenAlex ID:
A5108330387
Daratumumab in pediatric relapsed/refractory acute lymphoblastic leukemia or lymphoblastic lymphoma: the DELPHINUS study
2024
·
Teena Bhatla
, Laura E. Hogan
, et al.
·
Blood
·
74
Targeted therapies plus radiotherapy for diffuse intrinsic pontine glioma: the randomized phase 2 BIOMEDE trial
2026
·
Marie-Anne Debily
, Gwenael Le Teuff
, et al.
·
Nature Medicine
·
4
Population Pharmacokinetics of Bosutinib in Children with Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia Based on a Phase I Dose-Finding Trial (ITCC-054/COG AAML1921) and Pediatric Recommended Phase II Dosage Evaluation
2026
·
Jen-Hao Wu
, Francisco Bautista
, et al.
·
Clinical Pharmacokinetics
·
1
PDF
ID #1033 Impact of novel strategies in children diagnosed with DIPG
2026
·
Marta Perez-Somarriba
, Alba Brage
, et al.
·
Neuro-Oncology Pediatrics
Eligibility criteria in pediatric oncology phase I and II clinical trials: Analysis and recommendations for standardization from the Innovative Therapies for Children and Adolescents with Cancer (ITCC) Consortium
2026
·
Uri Ilan
, Alba Rubio-San-Simón
, et al.
·
European Journal of Cancer
First-year results of the International Leukemia/Lymphoma Target Board for pediatric relapsed and refractory hematological malignancies
2026
·
Uri Ilan
, Judith M. Boer
, et al.
·
Haematologica
PDF
Show more works
View as search
Works count:
6
Citation count:
79
H-index:
2
I10-index:
1
Year
Topic
Type